William Blair & Company
TBRA

William Blair & Company’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

William Blair & Company’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,115
Closed -$253K – 1342
2016
Q2 		$253K Sell
20,115
-17,115
-46% -$159K ﹤0.01% 1049
2016
Q1 		$304K Buy
37,230
+26,000
+232% +$196K ﹤0.01% 929
2015
Q4 		$112K Sell
11,230
-6,870
-38% -$71.4K ﹤0.01% 1142
2015
Q3 		$174K Hold
18,100
– – ﹤0.01% 1302
2015
Q2 		$312K Buy
+18,100
New +$265K ﹤0.01% 1925

Other funds holding TBRA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

William Blair & Company's TBRA Position: Q3 2016 in Review

William Blair & Company sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2016, closing a stake of 20,115 shares — an estimated $253K sold.

William Blair & Company first reported a position in TBRA in Q2 2015 and held it in 5 quarters. The position peaked at $312K in Q2 2015. 68 funds tracked by Wall St. Rank hold TBRA as of Q3 2016.

  • William Blair & Company reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • William Blair & Company sold 20,115 Tobira Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $253K.
  • William Blair & Company first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2015 and held it in 5 quarters.
  • William Blair & Company's Tobira Therapeutics, Inc. Common Stock position peaked at $312K in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2016.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.